Remove 2017 Remove Compounding Remove Prescription Filling
article thumbnail

Three strategies for managing loss of exclusivity successfully

pharmaphorum

Eli Lilly’s Humalog compound and formulation patents expired in 2013 and 2014, respectively. In late 2017, the FDA approved Admelog, Sanofi’s biosimilar of Humalog. Since losing exclusive rights in 2017, Pfizer undertook an over-the-counter switching strategy to guard against revenue loss.

article thumbnail

Ozempic statistics 2025

The Checkup by Singlecare

Ozempic was approved by the Food and Drug Administration (FDA) in 2017 for the treatment of Type 2 diabetes. How many people use compounded semaglutide? The number of people taking compounded semaglutide is difficult to accurately report because compounding pharmacies and facilities that make it arent required to report their sales.